2026 Global Biosimilars Market Midyear Review
Midyear assessment of the global biosimilar market, covering regulatory developments, product approvals, and dealmaking in the US and Europe during the first half of 2026.
Key Life Sciences Insights
Our team of scientists, strategists, economists, clinicians, and biostatisticians stay on the cutting edge of the evolving landscape. We collect their insights and the latest thinking and invite you to explore these resources.
Key Life Sciences Insights
Our team of scientists, strategists, economists, clinicians, and biostatisticians stay on the cutting edge of the evolving landscape. We collect their insights and the latest thinking and invite you to explore these resources.
Featured Publication
2026 Global Biosimilars Market Midyear Review
Access a midyear assessment of the global biosimilar market, covering regulatory developments, product approvals, and dealmaking in the US and Europe during the first half of 2026.
Alira Health Market Intelligence
Access our latest reports and white papers, featuring insights across multiple healthcare markets, including pharma, medtech, and more.
Global Biologics Contract Development and Manufacturing M&A Update 2026
Discover biologics CDMO M&A activity for 2026 with this one pager of insights into transaction volume, geographic distribution, capabilities, and modalities.
Global Medtech Contract Development and Manufacturing Market H1 2026 M&A Update
Learn about the H1 2026 M&A trends in the medtech CDMO market including deal activity, geographic distribution of transactions, and target end-markets.
Explore our Success Stories
Discover how we help our clients solve complex challenges. Explore our collection of case studies to learn more about our approach.
Myasthenia Gravis Patient Recruitment Campaign Enrolls Six Clinical Trial Patients in One Quarter
Learn how a targeted recruitment campaign helped enroll six patients in a myasthenia gravis clinical trial in just one quarter, accelerating recruitment.
Infection Control and Prevention Company Defines Winning US Market Entry Strategy
Discover how an infection prevention company defined a successful US market entry strategy amid regulatory uncertainty for novel wound care disinfectant products.
Small Biotech Company With Complex, Innovative Cell Immunotherapy in Oncology Executes Successful Phase Ib Clinical Trial Across Multiple Sites
Discover how a biotech company executed a complex Phase I trial with Alira Health, ensuring seamless coordination of manufacturing, logistics, and sites.
Expert Interviews
Discover expert interviews featuring thought leadership and practical insights from Alira Health specialists.
Rare Disease Trial Recruitment: The Role of Patient Registries
Explore how registries in rare disease trial recruitment connect sponsors with patient communities to improve identification and enrollment.
Clinical Trial Excellence in 2026: Managing the Complexity of Modern Clinical Development
Learn what clinical trial excellence means in complex product development and how biotech leaders can manage new complexity, risk, and executional pressure.
From Approval to Adoption: A New Framework for Medtech Success
Medtech success requires more than approval. Discover how aligning evidence, patient needs, and market access drives adoption.
Articles
Read our articles that provide insight to those innovating and developing in multiple healthcare markets, including pharma, medtech and more.
Patient Preference Studies: Patient Experience as Decision-Grade Evidence
Discover how patient preference studies use qualitative and quantitative methods to generate decision-Grade Evidence across development and commercialization.
FDA Initiatives and Programs to Support Development of Treatments for Rare Diseases in 2026
Discover FDA programs in 2026 that foster rare disease drug development, offering guidance, funding, and regulatory support for innovators.
How to Develop Global Clinical Evidence Strategies for Regulatory Success in Medtech
Discover how a strategically planned clinical evidence generation strategy can support global device approval, maximize evidence value, and prepare for international expansion.
Webinars
Listen to the latest insights from Alira Health experts featured in webinars. Just hit play!
Cross-Border Access to Rare Disease Clinical Trials: A Patient-Centric Approach to Feasibility and Execution
Watch the webinar to get practical insights on cross-border rare disease clinical trials and explore patient-centric strategies that support sponsor execution and patient access.
Global Payer Forum 2026
Educational webinar series about Value-Based Contracting by payers and academic experts and covering VBC fundamentals to success assessment.
Most Favored Nation: US Implementation and European Implications
This webinar explores how MFN pricing may impact US drug prices, access in Europe, launch strategies, and biotech investment.